glp-1 compounding news november 2025 Covering Drugs: Employers' Top Questions Answered – Sequoia GLP-1 Agonists Market Report 2025-2033,

It is important to note that Zepbound is not approved to treat type 2 diabetes under this brand name, even though its active ingredient (tirzepatide) is used in diabetes care under a different brand name (Mounjaro)

The information is, however, available in this blog

Credentials Breakdown LegitScript Certification Verified LegitScript certification is the industry gold standard for online healthcare providers, and Henry Meds certification shows it meets rigorous standards for safety, compliance, and trustworthy online practices

This method provides a non-invasive option, which could help overcome needle aversion in study participants